Modern Diagnostic & Research Centre (BOM:544673) Notes Receivable: ₹0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544673 Modern Diagnostic & Research Centre Ltd BOM:544673
15 GF Score
Price ₹51.00
! 7 Warning Signs
View Full Analysis

What is Modern Diagnostic & Research Centre Notes Receivable?

Modern Diagnostic & Research Centre BOM:544673 15 Notes Receivable is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:544673 with a GF Score™ of 15/100. The stock has 7 warning signs investors should review.

Modern Diagnostic & Research Centre's Notes Receivable for the quarter that ended in Mar. 2026 was ₹0.0 Mil.


Modern Diagnostic & Research Centre Notes Receivable Related Terms


Modern Diagnostic & Research Centre Notes Receivable Historical Data

* Premium members only.

The historical data trend for Modern Diagnostic & Research Centre's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Modern Diagnostic & Research Centre Notes Receivable Chart

Modern Diagnostic & Research Centre Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Notes Receivable
0.00 0.00 0.00 0.00

Modern Diagnostic & Research Centre Semi-Annual Data
Mar23 Mar24 Mar25 Mar26
Notes Receivable 0.00 0.00 0.00 0.00
BOM:544673
15GF Score
Modern Diagnostic & Research Centre Ltd BOM:544673
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Modern Diagnostic & Research Centre Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0.0 Mil mean?
Modern Diagnostic & Research Centre (BOM:544673) has a Notes Receivable of ₹0.0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Modern Diagnostic & Research Centre and its competitors.
Is Modern Diagnostic & Research Centre's Notes Receivable too high?
Modern Diagnostic & Research Centre's current Notes Receivable is ₹0.0 Mil. Overall, Modern Diagnostic & Research Centre has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Modern Diagnostic & Research Centre's Notes Receivable compare to TMO and DHR?
Modern Diagnostic & Research Centre's Notes Receivable of ₹0.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Diagnostics & Research company?
A good Notes Receivable depends on the Medical Diagnostics & Research industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Modern Diagnostic & Research Centre and its competitors. Modern Diagnostic & Research Centre's current Notes Receivable is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modern Diagnostic & Research Centre stock overvalued right now?
Modern Diagnostic & Research Centre (BOM:544673) has a current Notes Receivable of ₹0.0 Mil. The current Notes Receivable is ₹0.0 Mil. Modern Diagnostic & Research Centre's overall GF Score™ is 15/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Modern Diagnostic & Research Centre (BOM:544673), the current Notes Receivable is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Modern Diagnostic & Research Centre Business Description

Address New Railway Road, 363/4 Jawahar Nagar, Sadar Bazar, Gurugram, HR, IND, 122001
Modern Diagnostic & Research Centre Ltd is a services provider in diagnostic and related healthcare tests services in India. It offers a one-stop solution for pathology and radiology testing services such as imaging (including radiology), pathology/clinical laboratory. Through Its integrated, nationwide network, it offers a complete range of diagnostic facilities in radiology and pathology. The company provides healthcare tests and services for use in core testing, patients' diagnosis and prevention, monitoring of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
15GF Score

Get the complete analysis for BOM:544673

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹51.00
Price